Zurich Insurance Group (ZURN) H1 2021 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2021 earnings summary
17 Nov, 2026Executive summary
Business operating profit (BOP) rose 60% to $2.7bn and net income attributable to shareholders increased 86% to $2.2bn, despite elevated catastrophe and weather losses.
P&C underwriting improved to a 93.9% combined ratio, its lowest in more than 20 years; estimated SST ratio was 206%, above the 160% target.
Growth across businesses and lower COVID-related claims in P&C supported results; higher realized gains also lifted shareholder net income.
Financial highlights
Total revenues were $34.9bn vs. $22.5bn; net income before tax was $3.2bn vs. $1.6bn, and net income attributable to shareholders was $2.2bn vs. $1.2bn.
Basic EPS was $14.74 vs. $7.98; diluted EPS was $14.63 vs. $7.90.
Net investment result on Group investments rose to $3.1bn from $2.8bn, including net capital gains of $586m vs. $276m.
Net income growth reflected higher BOP and realized gains on equities and real estate; charges for items excluded from BOP increased slightly YoY.
Outlook and guidance
Remained on track to achieve 2022 targets; estimated SST ratio of 206% compared with the stated target of 160% or above.
Commercial insurance pricing continued to rise, supporting the outlook; first-half price increases were about 8%, well above claims cost inflation.
Strategy focused on protection, unit-linked and corporate savings products, which together represented 90% of Life APE sales.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023